Mayne Pharma acquires generics as Teva and Allergan clear path for FTC approval
MLex Summary: Australian pharmaceutical company Mayne Pharma has acquired a portfolio of generic products from Teva and Allergan. Israeli company Teva is looking to acquire Allergan’s generics unit, Actavis, and both...To view the full article, register now.
Already a subscriber? Click here to view full article